Detalhe da pesquisa
1.
Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity.
Pilot Feasibility Stud
; 9(1): 100, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37328890